Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risankizumab in Psoriasis
NCT04630652Phase 4Completed
- Sponsor
- Jaehwan Kim
- Start
- Apr 2021
- Primary completion
- May 2025
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of risankizumab in psoriasis, sponsored by Jaehwan Kim. Started Apr 2021; status: completed.
02
Drugs
risankizumab
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT04630652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04630652.